ArticleJournal of biomolecular techniques : JBT2009
Comparison of comparative genomic hybridization technologies across microarray platforms.
Article in Journal of biomolecular techniques : JBT, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 35 citations in OpenAlex.
- Comparative Genomic Hybridization (CGH) in Genotoxicology: From the Basics to Modern Approaches.Methods in molecular biology (Clifton, N.J.) · 2026Review
- Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization.Methods in molecular biology (Clifton, N.J.) · 2024Article
- Current status of structural variation studies in plants.Plant biotechnology journal · 2021Review
- DeepCNV: a deep learning approach for authenticating copy number variations.Briefings in bioinformatics · 2021Article
- Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.Molecular biology reports · 2018Article
- WISExome: a within-sample comparison approach to detect copy number variations in whole exome sequencing data.European journal of human genetics : EJHG · 2017Article
- Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms.Molecular oncology · 2015Article
- Hidden Markov Model-Based CNV Detection Algorithms for Illumina Genotyping Microarrays.Cancer informatics · 2014Review
- Expanding probe repertoire and improving reproducibility in human genomic hybridization.Nucleic acids research · 2013Article
- A discovery resource of rare copy number variations in individuals with autism spectrum disorder.G3 (Bethesda, Md.) · 2012Article
- Effect of Combining Multiple CNV Defining Algorithms on the Reliability of CNV Calls from SNP Genotyping Data.Genomics & informatics · 2012Article
- Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants.Nature biotechnology · 2011Article
- CNV-WebStore: online CNV analysis, storage and interpretation.BMC bioinformatics · 2011Article
- Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours.BMC research notes · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the 2007 Association of Biomolecular Resource Facilities Microarray Research Group project, we analyzed HL-60 DNA with five platforms: Agilent, Affymetrix 500K, Affymetrix U133 Plus 2.0, Illumina, and RPCI 19K BAC arrays. Copy number variation was analyzed using circular binary segmentation (CBS) analysis of log ratio scores from four independently assessed hybridizations of each platform. Data obtained from these platforms were assessed for reproducibility and the ability to detect formerly reported copy number variations in HL-60. In HL-60, all of the tested platforms detected genomic DNA amplification of the 8q24 locus, trisomy 18, and monosomy X; and deletions at loci 5q11.2~q31, 9p21.3~p22, 10p12~p15, 14q22~q31, and 17p12~p13.3. In the HL-60 genome, at least two of the five platforms detected five novel losses and five novel gains. This report provides guidance in the selection of platforms based on this wide-ranging evaluation of available CGH platforms.
Indexed as
Identifiers
19503625PMC2685605W341882553What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.